Solving Patient Matching in Rare Disease Trials

One of the most persistent barriers in rare disease drug development isn’t the science — it’s identifying and reaching the small number of patients who could benefit from emerging therapies. Without solving this, even the most promising innovations risk never reaching the people who need them most. In our latest podcast episode, we explore how the industry can better connect patients to clinical…